Skip to content

Opti-Relief

Bronson LaboratoriesUpdated April 2026

Product Information

Form
Capsule
UPC
7 16563 34002 5
Product Type
Other Combinations
DSLD Entry Date
2012-06-01

Target Groups

Adult (18 - 50 Years)

All Ingredients

IngredientAmount% DV
Astareal(R)6 mg
GliSODin(R)100 mg

† Daily Value not established.

Label Statements

Suggested/Recommended/Usage/Directions

DIRECTIONS: As a dietary supplement for adults, 1 capsule daily or as directed by a health professional.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General Statements: All Other Content

Lot No/Use By:

Brand IP Statement(s) re: (c), (TM), (SM)

Astareal(R) is a registered trademark of Fuji Chemical Industry Company. GliSODin(R) is a registered trademark of Isocell SA and of U.S. Patent nos. 6,045,809 and 6,426,068B1. Vcap(R) is a registered trademark of Capsugel.

General Statements: All Other Content

1109102 EXP:09/2012

Formula re: Contains

Contains Wheat

Storage

Store at room temperature. Protect from light.

Precautions re: Children

Keep out of reach of children.

General Statements: All Other Content

Made in USA

General Statements: All Other Content

EST. 1960

General Statements: All Other Content

SUPPORT FOR REDUCING EYE FATIGUE AND IMPROVING VISUAL ACUITY

FDA Statement of Identity

Dietary Supplement

General: Product/Version Code

No. 340B REF 0608

Supplement Facts Panel

Supplement Facts
Serving Size 1 Capsule(s)
Amount Per Serving% Daily Value*
Astareal(R)
6 mg
GliSODin(R)
100 mg

* Percent Daily Values are based on a 2,000 calorie diet.

† Daily Value not established.

Find on Amazon